PharmaLex Talks – Home of the Pharmalex Talks podcast
We recently launched a podcast to cover topics pertinent to the pharma industry. In our first podcast episode titled “Post Brexit landscape for the pharmaceutical industry” we talk about the following topics:
✔Adapting regulations Post-Brexit
✔What was the cost to the pharmaceutical industry as a result of Brexit, and the difficulties with the supply of safe and compliant medicines.
✔How have companies been approaching the requirements around the Northern Ireland Protocol.
✔How can pharma companies practically manage FMD requirements from January 2022.
✔What other deadlines should the pharma industry be aware of.
Our first guest is PharmaLex expert Charley Maxwell.
